Skip to main content
Lupin Ltd logo

Lupin Ltd — Investor Relations & Filings

Ticker · LUPIN ISIN · INE326A01037 LEI · 335800HHXTESDEE2FC65 BSE.NS Manufacturing
Open in API
Filings indexed 3,184 across all filing types
Latest filing 2020-08-14 Regulatory Filings
Country IN India
Listing BSE.NS LUPIN

About Lupin Ltd

https://www.lupin.com/

Lupin Ltd is a global pharmaceutical organization specializing in the development, manufacturing, and marketing of a comprehensive range of generic and branded formulations, biotechnology products, and active pharmaceutical ingredients. The company holds a significant market position in therapeutic segments such as cardiovascular, diabetology, asthma, pediatrics, gastrointestinal, anti-infectives, and non-steroidal anti-inflammatory drugs. It is notably recognized for its leadership in the anti-tuberculosis medication sector. With a strong emphasis on research and development, Lupin focuses on complex generics, specialty medicines, and biosimilars. The company operates advanced manufacturing facilities and maintains a substantial commercial presence across major global markets, including North America, Europe, and the Asia-Pacific region, delivering affordable and high-quality healthcare solutions.

Recent filings

Filing Released Lang Actions
Disclosure in respect of Grant of Stock Options
Regulatory Filings Classification · 95% confidence The document is a disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It announces the granting of stock options to employees under specific stock option plans, including the number of options and exercise price. The document is short (1769 characters) and is an announcement of a corporate action related to employee stock options. It does not contain financial statements, detailed financial analysis, or management discussion. It is not a report but a regulatory disclosure about share-based compensation. This fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories like Share Issue/Capital Change (SHA) because it is about stock options granted, not new share issuance or capital changes per se.
2020-08-14 English
Shareholders meeting
Regulatory Filings Classification · 80% confidence The document text is mostly unreadable or in an unrecognized script, with no clear English or recognizable keywords related to specific financial filings. There are no visible references to report titles, fiscal periods, regulatory bodies, or form names. The document length is about 9600 characters, which is substantial, but the content does not provide any clear indication of the document type. The presence of digital signatures suggests it is an official document, but without readable content or context, it cannot be classified as a specific report type such as Annual Report, Earnings Release, or Management Report. Given the lack of identifiable information and the fallback rule, the document should be classified as a Regulatory Filing (RNS).
2020-08-13 English
Scrutinizer''s Report for votes cast through remote e-voting and voting at the 38th Annual General Meeting held on Wednesday, August 12, 2020 through VC/OAVM.
Regulatory Filings Classification · 80% confidence The document text is mostly unreadable or in an unrecognized script, with no clear English or recognizable keywords related to specific financial filings. There are no visible references to report titles, fiscal periods, regulatory bodies, or form names. The document length is about 9600 characters, which is substantial, but the content does not provide any clear indication of being a financial report, announcement, or any specific filing type. The presence of digital signatures suggests it is an official document, but without readable content or context, it cannot be classified into any specific category. Therefore, by the fallback rule, this document should be classified as a Regulatory Filing (RNS).
2020-08-13 English
Mr. R. A. Shah (DIN: 00009851), Mr. Richard Zahn (DIN: 02937226), Dr. K. U. Mada (DIN: 00011395) and Mr. Dileep C. Choksi (DIN: 00016322), Independent Directors, retired at the conclusion ....
Board/Management Information Classification · 95% confidence The document is a letter addressed to stock exchanges disclosing information pursuant to Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements. It informs about the retirement of independent directors at the conclusion of the 38th Annual General Meeting. The content focuses on changes in the company's board of directors, specifically the retirement of independent directors after their terms. The document length is short (1261 characters), and it is not a full report but an announcement of board changes. Therefore, it fits the category of Board/Management Information (MANG).
2020-08-12 English
Change in Director(s)
Board/Management Information Classification · 95% confidence The document is a letter addressed to stock exchanges reporting the conclusion of the 38th Annual General Meeting (AGM) and the retirement of certain independent directors upon completion of their terms. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The content is an announcement about board changes following the AGM, specifically about independent directors retiring. The document is short (1280 characters) and does not contain financial data or detailed reports. Therefore, it is not an Annual Report or Management Report but an announcement related to board/management changes. Hence, the appropriate classification is Board/Management Information (MANG).
2020-08-12 English
Mr. K.B.S. Anand and Dr. Punita Kumar-Sinha Join Lupin Board as Independent Directors.
Board/Management Information Classification · 100% confidence The document is a formal announcement dated August 12, 2020, addressed to stock exchanges and regulatory bodies, disclosing the appointment of two new Independent Directors to the Board of Lupin Limited. It references compliance with Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements, which pertains to disclosure of material events including board changes. The content focuses on the appointment of board members, their backgrounds, and includes a press release. There is no financial data, earnings information, or report publication mentioned. The document is not a report itself but an announcement of management changes. Therefore, it fits the category of Board/Management Information (MANG). The document length (5875 characters) supports it being a full announcement rather than a brief notice or report publication announcement.
2020-08-12 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.